Literature DB >> 25460862

Cardiac late Na⁺ current: proarrhythmic effects, roles in long QT syndromes, and pathological relationship to CaMKII and oxidative stress.

Luiz Belardinelli1, Wayne R Giles2, Sridharan Rajamani3, Hrayr S Karagueuzian4, John C Shryock5.   

Abstract

Myocyte sodium channel current that persists throughout the plateau of the cardiac action potential is referred to as late sodium current (I(Na-L)). The magnitude of I(Na-L) is normally small, but can increase significantly in common acute and chronic pathological settings as a result of inherited and/or acquired Na(+) channelopathies that alter channel opening and closing (ie, gating), location (trafficking), or anchoring and interactions with cytoskeletal proteins. An increase in I(Na-L) reduces repolarization reserve in atrial and ventricular myocytes and prolongs the action potential duration and the QT interval. An enhanced I(Na-L) is a cause of long QT syndrome 3. I(Na-L) may be a cause of afterdepolarizations, triggered arrhythmias, and spontaneous diastolic depolarization-induced automaticity. In addition, enhancement of I(Na-L) increases both the temporal and the spatial dispersion of repolarization in the myocardium and may lead to spatially discordant action potential duration alternans, wavebreak, and reentrant arrhythmias. Positive feedback loops between increases in I(Na-L) and the activity of Ca(2+)/calmodulin-dependent protein kinase II appear to contribute to the genesis of arrhythmias and to certain abnormalities of the ischemic heart. In this review, we discuss some of the more relevant experimental results, clinical findings, and insights from cellular and animal models that highlight the role of I(Na-L) in the genesis of arrhythmias, long QT syndromes, and intracellular Ca(2+) homeostasis.
Copyright © 2015 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Afterpotential; Antiarrhythmic drug; Dispersion of repolarization; Long QT syndrome; Ranolazine; Reentry; Repolarization reserve; Triggered activity

Mesh:

Substances:

Year:  2014        PMID: 25460862     DOI: 10.1016/j.hrthm.2014.11.009

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  50 in total

Review 1.  A novel mechanism for the treatment of angina, arrhythmias, and diastolic dysfunction: inhibition of late I(Na) using ranolazine.

Authors:  Lars S Maier
Journal:  J Cardiovasc Pharmacol       Date:  2009-10       Impact factor: 3.105

Review 2.  Late sodium current: A mechanism for angina, heart failure, and arrhythmia.

Authors:  Jonathan C Makielski
Journal:  Trends Cardiovasc Med       Date:  2015-05-22       Impact factor: 6.677

Review 3.  Research progress on the role of CaMKII in heart disease.

Authors:  Shi-Jun Jiang; Wei Wang
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

4.  Late I(Na) in the Heart: Physiology, Pathology, and Pathways.

Authors:  Jonathan C Makielski; John W Kyle
Journal:  Circulation       Date:  2015-07-17       Impact factor: 29.690

Review 5.  Substrates and potential therapeutics of ventricular arrhythmias in heart failure.

Authors:  Dongze Zhang; Huiyin Tu; Michael C Wadman; Yu-Long Li
Journal:  Eur J Pharmacol       Date:  2018-06-27       Impact factor: 4.432

Review 6.  Pathophysiology of ventricular tachyarrhythmias : From automaticity to reentry.

Authors:  Andres Enriquez; David S Frankel; Adrian Baranchuk
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2017-05-31

7.  What currents underlie pulmonary vein automaticity?

Authors:  Shamone R Gore-Panter; David R Van Wagoner
Journal:  J Cardiovasc Electrophysiol       Date:  2015-01-13

8.  Calm down when the heart is stressed: Inhibiting calmodulin-dependent protein kinase II for antiarrhythmias.

Authors:  Dayue Darrel Duan
Journal:  Trends Cardiovasc Med       Date:  2015-02-07       Impact factor: 6.677

9.  Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study.

Authors:  Arthur A M Wilde; Arthur J Moss; Elizabeth S Kaufman; Wataru Shimizu; Derick R Peterson; Jesaia Benhorin; Coeli Lopes; Jeffrey A Towbin; Carla Spazzolini; Lia Crotti; Wojciech Zareba; Ilan Goldenberg; Jørgen K Kanters; Jennifer L Robinson; Ming Qi; Nynke Hofman; David J Tester; Connie R Bezzina; Marielle Alders; Takeshi Aiba; Shiro Kamakura; Yoshihiro Miyamoto; Mark L Andrews; Scott McNitt; Bronislava Polonsky; Peter J Schwartz; Michael J Ackerman
Journal:  Circulation       Date:  2016-08-26       Impact factor: 29.690

10.  The novel late Na+ current inhibitor, GS-6615 (eleclazine) and its anti-arrhythmic effects in rabbit isolated heart preparations.

Authors:  Sridharan Rajamani; Gongxin Liu; Nesrine El-Bizri; Donglin Guo; Cindy Li; Xiao-Liang Chen; Kristopher M Kahlig; Nevena Mollova; Elfatih Elzein; Jeff Zablocki; Luiz Belardinelli
Journal:  Br J Pharmacol       Date:  2016-09-14       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.